Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Eisai Co's Enterprise Value is 円1,670,737 Mil.
Eisai Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円73,447 Mil. Therefore, Eisai Co's EV-to-EBIT ratio for today is 22.75.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Eisai Co's Enterprise Value is 円1,670,737 Mil.
Eisai Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was 円112,997 Mil. Therefore, Eisai Co's EV-to-EBITDA ratio for today is 14.79.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Eisai Co's Enterprise Value is 円1,670,737 Mil.
Eisai Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was 円749,460 Mil. Therefore, Eisai Co's EV-to-Revenue ratio for today is 2.23.
Eisai Co Enterprise Value Historical Data
The historical data trend for Eisai Co's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Eisai Co's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Eisai Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eisai Co's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eisai Co's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Eisai Co's Enterprise Value falls into.
Eisai Co Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Eisai Co's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eisai Co (TSE:4523) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Eisai Co's current Enterprise Value is 円1,670,737 Mil.
Eisai Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円73,447 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Eisai Co's current Enterprise Value is 円1,670,737 Mil.
Eisai Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円112,997 Mil.
Eisai Co's current Enterprise Value is 円1,670,737 Mil.
Eisai Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円749,460 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eisai Co Enterprise Value Related Terms
Thank you for viewing the detailed overview of Eisai Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of a pharmaceutical business and other businesses. The pharmaceutical business is categorized by region, including Japan, Americas, China, Asia, and Europe, Middle East, and Africa. Eisai also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived by its Japanese pharmaceutical business, followed by its Americas pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4523 has been successfully added to your 